Maria Meringolo

631 total citations
24 papers, 461 citations indexed

About

Maria Meringolo is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Maria Meringolo has authored 24 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 10 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in Maria Meringolo's work include Neurological disorders and treatments (9 papers), Genetic Neurodegenerative Diseases (9 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Maria Meringolo is often cited by papers focused on Neurological disorders and treatments (9 papers), Genetic Neurodegenerative Diseases (9 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Maria Meringolo collaborates with scholars based in Italy, United Kingdom and United States. Maria Meringolo's co-authors include Paola Bonsi, Giuseppina Martella, Antonio Pisani, Giulia Ponterio, Annalisa Tassone, Aldo Badiani, Paola Imbriani, Nicola Biagio Mercuri, Antonella De Jaco and Tommaso Schirinzi and has published in prestigious journals such as Brain, International Journal of Molecular Sciences and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Maria Meringolo

24 papers receiving 458 citations

Peers

Maria Meringolo

CMN

NEURO

GENET

Ilaria Morella Italy

Kevin Chen United States

María Ramos Spain

D. Alex Gibson United States

Andrés Montefeltro Spain

Lilah Toker Israel

Xue-Min Gao United States

Albert Ferrés‐Coy Spain

Isabel Espadas Spain

Rebeca Martínez-Turrillas Spain

Ilaria Morella Italy

Maria Meringolo

168 ×0.7

CMN

189 ×1.3

75 ×0.5

NEURO

72 ×0.6

82 ×1.0

GENET

Citations per year, relative to Maria Meringolo Maria Meringolo (= 1×) peers Ilaria Morella

Countries citing papers authored by Maria Meringolo

Since Specialization

Citations

This map shows the geographic impact of Maria Meringolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Meringolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Meringolo more than expected).

Fields of papers citing papers by Maria Meringolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Meringolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Meringolo. The network helps show where Maria Meringolo may publish in the future.

Co-authorship network of co-authors of Maria Meringolo

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Meringolo. A scholar is included among the top collaborators of Maria Meringolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Meringolo. Maria Meringolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meringolo, Maria, Simona D’Antoni, Giuseppina Martella, et al.. (2025). Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C ‐Neuroligin 3 Mouse Model of Autism Spectrum Disorder. Journal of Neurochemistry. 169(10). e70253–e70253. 1 indexed citations

Ponterio, Giulia, Maria Meringolo, Giuseppina Martella, et al.. (2024). Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl cyclase/ cyclic AMP signaling pathway. Neurobiology of Disease. 191. 106403–106403. 5 indexed citations

Tassone, Annalisa, Maria Meringolo, Giulia Ponterio, et al.. (2023). Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson. International Journal of Molecular Sciences. 24(8). 7221–7221. 14 indexed citations

Ponterio, Giulia, Gaia Faustini, Giuseppe Sciamanna, et al.. (2022). Alpha‐Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction. Movement Disorders. 37(5). 949–961. 7 indexed citations

Cheng, Fubo, Peter A. Barbuti, Paola Bonsi, et al.. (2022). DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family. Brain. 145(11). 3968–3984. 6 indexed citations

Tassone, Annalisa, Giuseppina Martella, Maria Meringolo, et al.. (2021). Vesicular Acetylcholine Transporter Alters Cholinergic Tone and Synaptic Plasticity in DYT1 Dystonia. Movement Disorders. 36(12). 2768–2779. 12 indexed citations

Cascalho, Ana, Jef Swerts, Christine Klein, et al.. (2020). Excess Lipin enzyme activity contributes to TOR1A recessive disease and DYT-TOR1A dystonia. Brain. 143(6). 1746–1765. 16 indexed citations

Sciamanna, Giuseppe, Giulia Ponterio, Valentina Vanni, et al.. (2020). Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia. Cell Reports. 31(7). 107644–107644. 18 indexed citations

Meringolo, Maria, Yves Bourne, P. Marchot, et al.. (2020). The neuroligins and the synaptic pathway in Autism Spectrum Disorder. Neuroscience & Biobehavioral Reviews. 119. 37–51. 52 indexed citations

10.

Meringolo, Maria, et al.. (2018). Heroin versus cocaine: opposite choice as a function of context but not of drug history in the rat. Psychopharmacology. 236(2). 787–798. 15 indexed citations

11.

Bonsi, Paola, Giulia Ponterio, Valentina Vanni, et al.. (2018). RGS 9‐2 rescues dopamine D2 receptor levels and signaling in DYT 1 dystonia mouse models. EMBO Molecular Medicine. 11(1). 40 indexed citations

12.

Meringolo, Maria, Annalisa Tassone, Paola Imbriani, Giulia Ponterio, & Antonio Pisani. (2018). Dystonia: Are animal models relevant in therapeutics?. Revue Neurologique. 174(9). 608–614. 10 indexed citations

13.

Imbriani, Paola, Tommaso Schirinzi, Maria Meringolo, Nicola Biagio Mercuri, & Antonio Pisani. (2018). Centrality of Early Synaptopathy in Parkinson’s Disease. Frontiers in Neurology. 9. 103–103. 44 indexed citations

14.

Meringolo, Maria, et al.. (2017). Intravenous self‐administration of benzydamine, a non‐steroidal anti‐inflammatory drug with a central cannabinoidergic mechanism of action. Addiction Biology. 23(2). 610–619. 9 indexed citations

15.

Ponterio, Giulia, Annalisa Tassone, Giuseppe Sciamanna, et al.. (2017). Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia. Movement Disorders. 33(2). 310–320. 21 indexed citations

16.

Jaunarajs, Karen L. Eskow, Maria Meringolo, Francesca Romana Rizzo, et al.. (2017). Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia. Frontiers in Systems Neuroscience. 11. 43–43. 10 indexed citations

17.

Meringolo, Maria, et al.. (2015). Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting. Psychopharmacology. 232(13). 2415–2424. 18 indexed citations

18.

Meringolo, Maria, et al.. (2013). G.3 - THE ROLE OF ENVIRONMENTAL CONTEXT IN THE VULNERABILITY TO RELAPSE INTO HEROIN AND COCAINE ADDICTION. Behavioural Pharmacology. 24. e56–e57. 1 indexed citations

19.

Meringolo, Maria, et al.. (2012). The role of setting for ketamine abuse: clinical and preclinical evidence. Reviews in the Neurosciences. 23(5-6). 769–80. 31 indexed citations

20.

Meringolo, Maria, et al.. (2011). Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat. Psychopharmacology. 221(2). 195–203. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact